Actively Recruiting
Donor CHIP and Allogeneic HSCT Outcome
Led by The University of Hong Kong · Updated on 2022-10-04
850
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Current data on the impact of donor CHIP on long-term recipient outcome remain largely speculative. Data on the impact of donor CHIP including on allograft function, immunologic dysfunction, graft versus host disease (GVHD), disease relapse and survival across various donor populations are scarce. This is a retrospective-prospective cohort study designed to determine the association between donor gene mutations and outcome following allogeneic HSCT.
CONDITIONS
Official Title
Donor CHIP and Allogeneic HSCT Outcome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult aged 18 year or above
- Donor and recipient of allo-HSCT
- Provided signed written informed consent for clinical data and specimen use in prospective or partial prospective/retrospective cases
- Provided prior signed written informed consent for voluntary use of archived specimens in retrospective cases
You will not qualify if you...
- Autologous peripheral blood stem cells or bone marrow stem cell donors for autologous HSCT
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
H
Harinder Gill, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here